Clearmind Medicine Inc. (CMND)

Balance Sheet (Annual)

Financials in millions CAD. Fiscal year is November - October.

Year	2022	2021	2020
Cash & Equivalents	0.18	4.6	0.33
Short-Term Investments	0.26	0	0
Cash & Cash Equivalents	0.44	4.6	0.33
Cash Growth	-90.43%	1294.44%	-
Receivables	0.07	0.16	0
Other Current Assets	0.08	0.16	0
Total Current Assets	0.59	4.92	0.33
Property, Plant & Equipment	0.07	0.02	0
Long-Term Investments	0.02	0.02	0
Goodwill and Intangibles	0.18	0.2	0
Other Long-Term Assets	0.27	0	0
Total Long-Term Assets	0.53	0.24	0
Total Assets	1.13	5.16	0.33
Accounts Payable	2.19	0.36	0.01
Current Debt	0.05	0	0
Other Current Liabilities	0.4	0	0
Total Current Liabilities	2.64	0.36	0.01
Total Liabilities	2.64	0.36	0.01
Total Debt	0.05	0	0
Common Stock	12.37	9.24	1.04
Retained Earnings	-13.85	-4.44	-0.72
Comprehensive Income	-0.03	0	0
Shareholders' Equity	-1.51	4.8	0.32
Total Liabilities and Equity	1.13	5.16	0.33
Net Cash / Debt	0.39	4.6	0.33
Net Cash / Debt Growth	-91.57%	1294.44%	-
Net Cash Per Share	0.30	4.96	0.61
Working Capital	-2.04	4.56	0.32
Book Value Per Share	-1.16	5.18	0.59

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).